To further explore the relationship between HNF4A and cervical cancer, the Kaplan–Meier estimator survival analysis in TCGA database revealed that the patients who have higher expression of HNF4A would obtain higher relapse-free survival (RFS) probability. Here, HNF4A is linked to cervical cancer.